These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 22368272)

  • 21. IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
    Dörge P; Meissner B; Zimmermann M; Möricke A; Schrauder A; Bouquin JP; Schewe D; Harbott J; Teigler-Schlegel A; Ratei R; Ludwig WD; Koehler R; Bartram CR; Schrappe M; Stanulla M; Cario G
    Haematologica; 2013 Mar; 98(3):428-32. PubMed ID: 22875627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRLF2 expression associates with ICN1 stabilization in T-cell acute lymphoblastic leukemia.
    Maciel ALT; Poubel CP; Noronha EP; Pombo-de-Oliveira MS; Mansur MB; Emerenciano M
    Genes Chromosomes Cancer; 2019 Jun; 58(6):396-401. PubMed ID: 30578688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IKZF1
    Stanulla M; Dagdan E; Zaliova M; Möricke A; Palmi C; Cazzaniga G; Eckert C; Te Kronnie G; Bourquin JP; Bornhauser B; Koehler R; Bartram CR; Ludwig WD; Bleckmann K; Groeneveld-Krentz S; Schewe D; Junk SV; Hinze L; Klein N; Kratz CP; Biondi A; Borkhardt A; Kulozik A; Muckenthaler MU; Basso G; Valsecchi MG; Izraeli S; Petersen BS; Franke A; Dörge P; Steinemann D; Haas OA; Panzer-Grümayer R; Cavé H; Houlston RS; Cario G; Schrappe M; Zimmermann M; ;
    J Clin Oncol; 2018 Apr; 36(12):1240-1249. PubMed ID: 29498923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia.
    Palmi C; Savino AM; Silvestri D; Bronzini I; Cario G; Paganin M; Buldini B; Galbiati M; Muckenthaler MU; Bugarin C; Della Mina P; Nagel S; Barisone E; Casale F; Locatelli F; Lo Nigro L; Micalizzi C; Parasole R; Pession A; Putti MC; Santoro N; Testi AM; Ziino O; Kulozik AE; Zimmermann M; Schrappe M; Villa A; Gaipa G; Basso G; Biondi A; Valsecchi MG; Stanulla M; Conter V; Te Kronnie G; Cazzaniga G
    Oncotarget; 2016 Sep; 7(37):59260-59272. PubMed ID: 27449287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overall characterization of pediatric acute lymphoblastic leukemia with CRLF2 overexpression.
    Yano M; Imamura T; Asai D; Moriya-Saito A; Suenobu S; Hasegawa D; Deguchi T; Hashii Y; Kawasaki H; Hori H; Kosaka Y; Kato K; Horibe K; Yumura-Yagi K; Hara J; Matsumoto K; Kiyokawa N; Oda M; Sato A;
    Genes Chromosomes Cancer; 2014 Oct; 53(10):815-23. PubMed ID: 24935070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study.
    Michels N; Boer JM; Enshaei A; Sutton R; Heyman M; Ebert S; Fiocco M; de Groot-Kruseman HA; van der Velden VHJ; Barbany G; Escherich G; Vora A; Trahair T; Dalla-Pozza L; Pieters R; Zur Stadt U; Schmiegelow K; Moorman AV; Zwaan CM; den Boer ML
    Lancet Haematol; 2021 Oct; 8(10):e700-e710. PubMed ID: 34560013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unravelling the prognostic effect of IKZF1 deletions and IGH@-CRLF2 in adult acute lymphoblastic leukaemia.
    O'Reilly J; Russell LJ; Cooney J; Ensor HM; Purtill D; Wright M; Moorman AV
    Pathology; 2013 Oct; 45(6):609-12. PubMed ID: 24018820
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.
    Borowitz MJ; Devidas M; Hunger SP; Bowman WP; Carroll AJ; Carroll WL; Linda S; Martin PL; Pullen DJ; Viswanatha D; Willman CL; Winick N; Camitta BM;
    Blood; 2008 Jun; 111(12):5477-85. PubMed ID: 18388178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refining risk stratification in paediatric B-acute lymphoblastic leukaemia: Combining IKZF1
    Liu HC; Huang YJ; Jaing TH; Wu KH; Chen SH; Wang SC; Yeh TC; Hsiao CC; Chang TK; Yen HJ; Huang FL; Lin PC; Hou JY; Sheen JM; Liao YM; Chang TY; Chen YC; Chiou SS; Yang CP; Pui CH; Liang DC; Shih LY
    Br J Haematol; 2024 Apr; 204(4):1344-1353. PubMed ID: 38479427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance and treatment strategies for IKZF1 deletion in pediatric B-cell precursor acute lymphoblastic leukemia.
    Pan L; Chen Y; Weng K; Guo B; Zhuang S; Huang S; Lian Z; Wang X; Li N; Zheng Y
    BMC Cancer; 2024 Aug; 24(1):1070. PubMed ID: 39210321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities.
    Chiaretti S; Brugnoletti F; Messina M; Paoloni F; Fedullo AL; Piciocchi A; Elia L; Vitale A; Mauro E; Ferrara F; De Fabritiis P; Luppi M; Ronco F; De Propris MS; Raponi S; Kronnie GT; Vignetti M; Guarini A; Foà R
    Leuk Res; 2016 Feb; 41():36-42. PubMed ID: 26754556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
    Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E
    Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical Features and Prognosis of Acute Lymphoblastic Leukemia Children with P2RY8-CRLF2 Gene Rearrangement].
    Zheng YZ; LE SH; Zheng H; Hua XL; Chen ZS; Zheng L; Chen C; Li M; Cai CX; Yang JH; Chen YQ; Gao QL; Chen YY; Li J; Hu JD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):311-315. PubMed ID: 33812392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The application of targeted RNA sequencing for the analysis of fusion genes, gene mutations, IKZF1 intragenic deletion, and CRLF2 overexpression in acute lymphoblastic leukemia.
    Zhang Z; Jing Y; Chen B; Zhang H; Liu T; Dong S; Zhang L; Yan X; Yang S; Chen L; Lin Y; Ru K
    Int J Lab Hematol; 2024 Aug; 46(4):670-677. PubMed ID: 38553845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biology of Philadelphia chromosome-like ALL.
    Roberts KG
    Best Pract Res Clin Haematol; 2017 Sep; 30(3):212-221. PubMed ID: 29050694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
    Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
    [No Abstract]   [Full Text] [Related]  

  • 37. IKZF1
    Kovach AE; Wengyn M; Vu MH; Doan A; Raca G; Bhojwani D
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30996. PubMed ID: 38637852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characterization and prognosis of T cell acute lymphoblastic leukemia with high CRLF2 gene expression in children.
    Wang M; Wen J; Guo Y; Shen Y; An X; Hu Y; Xiao J
    PLoS One; 2019; 14(12):e0224652. PubMed ID: 31830053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.
    Loh ML; Zhang J; Harvey RC; Roberts K; Payne-Turner D; Kang H; Wu G; Chen X; Becksfort J; Edmonson M; Buetow KH; Carroll WL; Chen IM; Wood B; Borowitz MJ; Devidas M; Gerhard DS; Bowman P; Larsen E; Winick N; Raetz E; Smith M; Downing JR; Willman CL; Mullighan CG; Hunger SP
    Blood; 2013 Jan; 121(3):485-8. PubMed ID: 23212523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia.
    Tran TH; Harris MH; Nguyen JV; Blonquist TM; Stevenson KE; Stonerock E; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJG; Reshmi SC; Neuberg DS; Sallan SE; Loh ML; Silverman LB
    Blood Adv; 2018 Mar; 2(5):529-533. PubMed ID: 29507076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.